Biochips and detection methods

By employing polymers with modified side chains in biochips, the issues of varying detection sensitivity and noise are addressed, resulting in improved signal-to-noise ratios for accurate molecular identification and diagnosis.

JP7578907B2Active Publication Date: 2024-11-07TORAY INDUSTRIES INC
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
JP2020561102
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-11-15
Filing Date
2020-10-29
Publication Date
2024-11-07
Estimated Expiration
2040-10-29

AI Technical Summary

Technical Problem

Existing biochips face challenges in achieving high signal-to-noise ratios due to variations in detection sensitivity when immobilizing selective binding substances on substrates, despite using amino group-containing polymers like polyethyleneimine and polyallylamine, as they often result in increased noise values alongside improved signal values.

Method used

The use of polymers with modified side chain structures, specifically represented by formulas (Ia) and (Ib), immobilized on substrates to create biochips with enhanced signal values and reduced noise, utilizing heteropolymers with controlled ratios of these units for improved performance.

Benefits of technology

The proposed biochips achieve higher signal-to-noise ratios, enabling more accurate molecular identification and diagnosis by minimizing non-specific binding and optimizing the substrate surface for selective binding.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007578907000001
    Figure 0007578907000001
  • Figure 0007578907000002
    Figure 0007578907000002
  • Figure 0007578907000003
    Figure 0007578907000003
Patent Text Reader

Abstract

Disclosed are: a biochip capable of detecting, with high sensitivity, a substance to be measured; and a method for detecting the substance to be measured using the same. In the biochip, a selectively bindable substance capable of selectively binding to a substance to be measured is immobilized on the surface of a substrate via a polymer including a unit represented by formula (Ia) or formula (Ib). In formula (Ia) and formula (Ib), R1 represents an alkylene group having 1 to 4 carbon atoms, R2 represents R3, OR4, or NHR5, R3 and R5 each independently represent a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, R4 represents an alkyl group having 1 to 4 carbon atoms, R6 represents an alkylene group having 1 or 2 carbon atoms, and R7 and R8 each independently represent a hydrogen atom or an alkyl group having 1 to 4 carbon atoms.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a biochip having a substance that selectively binds to a target substance (herein referred to as a "selective binding substance") immobilized on the surface of a substrate, and a method for detecting a target substance using the biochip. [Background technology]

[0002] A biochip having selective binding substances such as nucleic acids and proteins immobilized on a substrate detects fluorescence after selective binding with a substance to be measured, and molecular identification and diagnosis can be performed from the intensity change and pattern. For accurate molecular identification and diagnosis using a biochip, it is desirable for the performance of the biochip to be high in detection sensitivity for the substance to be measured. Specifically, it is desirable for the signal value to be high when detecting the fluorescence of the substance to be measured, and for the signal value / noise value ratio (hereinafter referred to as "SN ratio") to be high.

[0003] In biochips, the detection sensitivity of the measurement target substance may vary depending on the method of immobilizing selective binding substances such as nucleic acids and proteins on a substrate. For example, it has been reported that a biochip with high detection sensitivity can be manufactured by immobilizing selective binding substances on the substrate surface via a polymer (Patent Documents 1 and 2). The polymers used in this case are often "amino group-containing polymers" that have amino groups in their chemical structures, such as polyethyleneimine, polyallylamine, and poly-L-lysine. Patent Document 1 discloses a biochip in which a selective binding substance is immobilized on the substrate surface via polyethyleneimine, a type of amino group-containing polymer. [Prior art documents] [Patent documents]

[0004] [Patent Document 1] WO 01 / 70641 [Patent Document 2] WO 01 / 70851 Summary of the Invention [Problem to be solved by the invention]

[0005] In order to develop a biochip capable of detection with a high S / N ratio, the present inventors immobilized a selective binding substance on a substrate with reference to Patent Document 1 to prepare a biochip. Specifically, a biochip was prepared in which a selective binding substance was immobilized on the substrate surface via polyethyleneimine, a type of amino group-containing polymer (Comparative Example 2 described below). The signal value was improved compared to a biochip in which a selective binding substance was immobilized by condensation directly on the substrate surface without the use of a polymer (Comparative Example 1 described below), but the noise value also increased, and no improvement in the S / N ratio was observed. Therefore, the immobilization of a selective binding substance on a substrate via polyallylamine, another amino group-containing polymer, was examined (Comparative Example 3 described below). The signal value was further improved compared to a biochip in which a selective binding substance was immobilized via polyethyleneimine, but the noise value also increased, and the improvement in the S / N ratio was not sufficient. In other words, it was found that simply immobilizing a selective binding substance via an amino group-containing polymer does not necessarily lead to an improvement in the signal value and S / N ratio, and that in order to obtain a biochip with excellent signal value and S / N ratio, it is necessary to consider the structure of the amino group-containing polymer, in particular the side chain structure of the polymer. [Means for solving the problem]

[0006] In order to overcome the above problems, the present inventors investigated polymer structures suitable for biochips and found that by using a polymer with a modified side chain structure, a biochip with a high signal value and a high S / N ratio can be obtained.

[0007] That is, the present invention provides the following (1) to ( 8 ) is provided. (1) A biochip comprising a substrate having a surface on which a selective binding substance capable of selectively binding to a substance to be measured is immobilized via a polymer containing a unit represented by formula (Ia) or formula (Ib).

[0008] [ka] TIFF0007578907000002.tif8449

[0009] In formula (Ia) and formula (Ib), R 1 represents an alkylene group having 1 to 4 carbon atoms, R 2 is R 3 , OR 4 or NHR 5 R 3 and R 5 each independently represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms; R 4 represents an alkyl group having 1 to 4 carbon atoms, and R 6 represents an alkylene group having 1 to 2 carbon atoms, R 7 and R 8 each independently represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms. (2) The polymer is represented by the formula (Ia), 1 and R 2 The biochip according to (1), wherein the definition is the same as that in (1). (3) The polymer is represented by the formula (Ib), 6 , R 7 and R 8 The biochip according to (1), wherein the definition is the same as that in (1). (4) The biochip according to any one of (1) to (3), wherein the polymer is a heteropolymer. (5) The biochip according to (4), wherein the heteropolymer is a heteropolymer with a unit represented by formula (II).

[0010] [ka]

[0011] In the formula, R 1 represents an alkylene group having 1 to 4 carbon atoms. (6) The biochip according to any one of (1) to (5), wherein the polymer has a number average molecular weight of 300 to 1,000,000. (7) The biochip according to any one of (1) to (6), wherein the selective binding substance is a nucleic acid or a protein. (8) A method for detecting a substance to be measured using the biochip according to any one of (1) to (7), in which a selective binding substance capable of selectively binding to the substance to be measured is immobilized on the surface of a substrate, the method comprising the steps of contacting a sample containing the substance to be measured with the surface of the substrate and detecting a complex formed with the selective binding substance. Effect of the Invention

[0012] By immobilizing a selective binding substance on a substrate via a polymer containing a unit represented by formula (Ia) or formula (Ib), particularly a heteropolymer of a unit represented by formula (Ia) or formula (Ib) and a unit represented by formula (II), a biochip capable of detecting a substance to be measured with high sensitivity can be provided. By using the biochip of the present invention, more accurate molecular identification and diagnosis are possible. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0013] The biochip of the present invention is characterized in that a substance capable of selectively binding to a substance to be measured is immobilized on a substrate via a polymer containing a unit represented by formula (Ia) or formula (Ib).

[0014] R in formula (Ia) and formula (Ib) 1 R represents an alkylene group having 1 to 4 carbon atoms. 1 is preferably a methylene group having 1 carbon atom and an ethylene group having 2 carbon atoms, and more preferably a methylene group having 1 carbon atom.

[0015] R in formula (Ia) 2 is R 3 , OR 4 or NHR 5 R 3 and R 5each independently represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms; R 4 R represents an alkyl group having 1 to 4 carbon atoms. 3 R is preferably a methyl group having 1 carbon atom or an ethyl group having 2 carbon atoms, and more preferably a methyl group having 1 carbon atom. 4 R is preferably a methyl group having 1 carbon atom or an ethyl group having 2 carbon atoms, and more preferably a methyl group having 1 carbon atom. 5 is preferably a hydrogen atom.

[0016] R in formula (Ib) 6 R represents an alkylene group having 1 to 2 carbon atoms. 6 is preferably an ethylene group having 2 carbon atoms.

[0017] R in formula (Ib) 7 and R 8 R each independently represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms. 7 and R 8 is preferably a hydrogen atom or a methyl group having 1 carbon atom, and more preferably a hydrogen atom.

[0018] The polymer may be a heteropolymer containing a unit represented by formula (Ia) or (Ib), and may be a heteropolymer containing a unit other than the unit represented by formula (Ia) or (Ib). In the case of a heteropolymer, when the polymer is immobilized on a substrate surface by covalent bonding, the unit other than the unit represented by formula (Ia) or (Ib) preferably has a reactive functional group. Examples of the reactive functional group include an amino group, a carboxyl group, a hydroxyl group, a halogeno group, a tosyl group, an epoxy group, an acyl group, and an azide group, and preferably an amino group. In the case of a heteropolymer, the ratio of the unit represented by formula (Ia) or (Ib) (hereinafter, these may be collectively referred to as formula (I) for convenience) to the total units is preferably 5 mol% or more and 95 mol% or less, more preferably 10 mol% or more and 90 mol% or less, and even more preferably 30 mol% or more and 70 mol% or less.

[0019] When the polymer containing the unit represented by formula (Ia) or (Ib) is a heteropolymer, it is preferably a heteropolymer containing the unit represented by formula (II). 1 R in formula (Ia) or (Ib) 1 Similarly, m represents an alkylene group having 1 to 4 carbon atoms. In this heteropolymer, the ratio of the unit represented by formula (I) to the total of the unit represented by formula (I) and the unit represented by formula (II) ((m / (m+n)) described later) is preferably 5 mol % or more and 95 mol % or less, more preferably 10 mol % or more and 90 mol % or less, and further preferably 30 mol % or more and 70 mol % or less.

[0020] As a method for producing a polymer containing a unit represented by formula (I), there are two methods, as shown in the following scheme: (A) using a monomer represented by formula (III) as a raw material, polymerizing the polymer and then modifying the side chain amino group; and (B) using a monomer represented by formula (III) as a raw material, modifying the side chain amino group, and then polymerizing the polymer. Of these, the former method (A) is preferred.

[0021] [ka]

[0022] R in formula (III) 1 R in formula (Ia) and (Ib) 1 Similarly, it represents an alkylene group having 1 to 4 carbon atoms. The monomer represented by formula (III) is available from a reagent manufacturer (for example, Merck, Enamine, etc.).

[0023] The polymerization of the monomer represented by formula (III) in the above method (A) can be carried out using radical polymerization. For example, 0.1 to 30 mol % of an azo radical polymerization initiator (e.g., 2,2'-azobis(2-amidinopropane) dihydrochloride, etc.) based on the monomer is added to a 10 to 80 wt % monomer solution, and the mixture is reacted for 3 to 100 hours at room temperature to 80°C. In addition, 1A homopolymer of a monomer in which is a methylene group having one carbon atom can also be obtained from a reagent manufacturer (for example, Nittobo Medical Co., Ltd.).

[0024] As a method for modifying the side chain amino group after polymerization of the monomer represented by formula (III), a method of reacting with an amino group modifying reagent as follows can be mentioned.

[0025] R in formula (Ia) 2 R 3 Where R 3 When R is a hydrogen atom, a formylating agent such as 1-formylpiperidine can be used as a reagent for modifying the amino group. 3 When R is an alkyl group having 1 to 4 carbon atoms, an acid anhydride such as acetic anhydride, propionic anhydride, butyric anhydride, or valeric anhydride (R 3 CO2COR 3 ) can be used.

[0026] R in formula (Ia) 2 OR 4 In this case, diester carbonates such as dimethyl carbonate, diethyl carbonate, dipropyl carbonate, and dibutyl carbonate can be used as reagents for modifying amino groups (R 4 OCO2R 4 ) can be used.

[0027] R in formula (Ia) 2 NHR 5 In this case, an isocyanate derivative (R 5 -NCO) can be used.

[0028] R in formula (Ib) 6When is a methylene group having one carbon atom, examples of reagents for modifying amino groups include bromoacetamide derivatives (BrCH2CONR) such as 2-bromoacetamide, 2-bromo-N-methylacetamide, 2-bromo-N-ethylacetamide, 2-bromo-N-propylacetamide, 2-bromo-N-isopropylacetamide, 2-bromo-N-butylacetamide, 2-bromo-N,N-dimethylacetamide, and 2-bromo-N,N-diethylacetamide. 7 R 8 ) can be used.

[0029] R in formula (Ib) 6 is an ethylene group having two carbon atoms, examples of reagents for modifying amino groups include acrylamide derivatives (CH2=CHCONR) such as acrylamide, N-methylacrylamide, N-ethylacrylamide, N-propylacrylamide, N-isopropylacrylamide, N-butylacrylamide, N,N-dimethylacrylamide, and N,N-diethylacrylamide. 7 R 8 ) can be used.

[0030] The reaction between the above-mentioned amino group modifying reagent and the polymer of the monomer represented by formula (III) can be carried out, for example, by adding the amino group modifying reagent to a 10 to 50 wt % polymer solution and reacting for 3 to 100 hours at room temperature to 80°C.

[0031] The side chain modification of the monomer represented by formula (III) in the above method (B) can be carried out using an amino group modification reagent in the same manner as above, and the polymerization of the modified monomer can also be carried out under the same general conditions as above.

[0032] Formula (Ia) or Formula ( IIn the production of a heteropolymer of a unit represented by formula (b) and a unit represented by formula (II), only a part of the side chain amino groups may be modified in the above-mentioned side chain amino group modification step. In particular, in the above-mentioned method (A), it is preferable to use a method in which only a part of the side chain amino groups of a polymer of a monomer represented by formula (III) is modified. In this case, the unit represented by formula (Ia) or formula ( I The ratio of the unit represented by formula (b) to the unit represented by formula (II) can be adjusted by adjusting the molar ratio of the side chain amino group in the polymer and the reagent for modifying the amino group used. I The ratio of the units represented by b) to the units represented by formula (II) is 1 It can be calculated by H-NMR measurement.

[0033] The molecular weight of the polymer in the biochip of the present invention is, in terms of number average molecular weight, preferably 300 to 1,000,000, more preferably 1,000 to 100,000, and even more preferably 1,600 to 25,000. The molecular weight of the polymer can be calculated, for example, by gel permeation chromatography (GPC) using polyethylene glycol as a standard.

[0034] The material of the substrate of the biochip of the present invention may be any of resin, glass, metal, and silicon wafer, but resin is preferred from the viewpoints of ease of surface treatment and mass productivity.

[0035] Examples of resins that can be used as the material for the substrate include polyacrylic acid esters, polymethacrylic acid esters, polycarbonates, polystyrenes, polyvinyl acetates, polyesters, etc., with polyacrylic acid esters and polymethacrylic acid esters being preferred. Among these, examples of polymethacrylic acid esters include polyalkyl methacrylates (PAMAs) such as polymethyl methacrylate (PMMA), polyethyl methacrylate (PEMA), and polypropyl methacrylate, with PMMA being preferred.

[0036] Also, known copolymers can be used as the resin, such as acrylonitrile-styrene copolymer (AS resin), acrylonitrile-butadiene-styrene copolymer (ABS resin), acrylonitrile-ethylene-propylene-diene-styrene copolymer (AES resin), and copolymers containing polymethacrylate esters, such as methyl methacrylate-acrylonitrile-butadiene-styrene copolymer (MABS resin), methyl methacrylate-butadiene-styrene copolymer (MBS resin), and methyl methacrylate-styrene copolymer (MS resin).

[0037] The polymer may be immobilized on the substrate surface by physical adsorption or covalent bonding, with covalent bonding being preferred from the viewpoint of preventing the polymer from peeling off or eluting from the substrate during substrate cleaning.

[0038] The method of immobilizing the polymer on the substrate surface by physical adsorption includes preparing a polymer solution by dissolving the polymer in an organic solvent to a concentration of 0.05 to 10% by weight, applying the polymer to the substrate surface by a known method such as immersion or spraying, and then drying at room temperature or under heating. As the organic solvent, a single solvent such as ethanol, methanol, t-butyl alcohol, benzene, toluene, tetrahydrofuran, dioxane, dichloromethane, chloroform, acetone, methyl ethyl ketone, or a mixture of these solvents is used. When the substrate is made of resin, it is preferable to use ethanol or methanol as the organic solvent because it does not denature the substrate and is easy to dry.

[0039] The method of immobilizing the above-mentioned polymer on the substrate surface by a covalent bond can be a method of reacting a functional group present in the polymer with a functional group present on the substrate surface to form a covalent bond. The functional group present on the substrate surface can be an amino group, a carboxyl group, a hydroxyl group, a halogeno group, etc., and the form of the covalent bond can be any of an amide bond, an ester bond, an ether bond, etc., but an amide bond is preferred from the viewpoint of ease and strength of bond formation.

[0040] As a method for immobilizing the above-mentioned polymer on the substrate surface through an amide bond, a method in which an amino group present in the polymer is reacted with a carboxyl group present on the substrate surface may be used, or a method in which a carboxyl group present in the polymer is reacted with an amino group present on the substrate surface may be used, but a method in which an amino group present in the polymer is reacted with a carboxyl group present on the substrate surface is more preferred.

[0041] The immobilization of a polymer having an amino group by a condensation reaction with a carboxyl group present on the substrate surface may be carried out by directly reacting the carboxyl group on the substrate surface with the amino group in the polymer using a condensation agent such as 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (also known as 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC)) or 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (DMT-MM), or by converting the carboxyl group on the substrate surface to an activated ester using N-hydroxysuccinimide (NHS) or the like, and then reacting the carboxyl group with the amino group in the polymer.

[0042] When no functional group capable of reacting with a polymer is present on the surface of the substrate, a functional group capable of reacting with a polymer can be generated on the surface of the substrate by a method suitable for the material of the substrate.

[0043] Examples of methods for generating functional groups on the surface of a resin substrate include immersing the substrate in a solution containing a compound having a desired functional group, and oxidizing the resin on the substrate surface by exposure to UV, radiation, ozone, or plasma. Examples of methods for generating carboxyl groups on the surface of a resin substrate include hydrolysis of the substrate surface with alkali, acid, or the like, ultrasonic treatment of the substrate surface in warm water, irradiating the substrate surface with UV or ozone, and exposing the substrate surface to oxygen plasma, argon plasma, or radiation. When the resin is a resin having an ester structure in the side chain, such as polyacrylic acid ester or polymethacrylic acid ester, the substrate can be immersed in alkali or acid to hydrolyze the ester structure on the resin surface, thereby generating carboxyl groups on the substrate surface. As a specific example, the resin substrate can be immersed in an aqueous solution of sodium hydroxide or sulfuric acid (preferably 1N to 20N) and held at a temperature of preferably 30°C to 80°C for 1 hour to 100 hours. In the case of a resin that does not have an ester structure in the side chain, a carboxyl group can be generated on the substrate surface by oxidizing the carbon atoms on the resin surface by plasma treatment in the presence of oxygen.

[0044] A method for generating functional groups on the surface of a glass substrate includes a method of reacting a silane coupling agent having a desired functional group. In addition, a method of converting a functional group introduced by a reaction with a silane coupling agent into another functional group by reacting it with a compound having another functional group can also be used. As a method for generating a carboxyl group among functional groups on the surface of a glass substrate, a method of reacting a dicarboxylic anhydride such as succinic anhydride with an amino group generated by reacting a silane coupling agent such as 3-aminopropyltriethoxysilane with a silanol group on the substrate surface can be used.

[0045] Methods for generating functional groups on the surface of a metal substrate include a method of reacting a silane coupling agent having a desired functional group, a method of reacting an alkanethiol having a desired functional group, etc. As a method for generating a carboxyl group among functional groups on the surface of a metal substrate, in addition to the above method of generating a carboxyl group on the surface of a glass substrate, a method of reacting an alkanethiol having a carboxyl group, such as 5-carboxy-1-pentanethiol, with the substrate can be used.

[0046] As a method for generating functional groups on the surface of a silicon wafer substrate, a method similar to that for generating functional groups on the surface of a glass substrate can be used.

[0047] In the biochip of the present invention, a selective binding substance is immobilized on the surface of the substrate via the above-mentioned polymer. The term "selective binding substance" as used herein means a substance that can selectively bind directly or indirectly to a substance to be measured, and representative examples include nucleic acids, proteins, sugars, and other antigenic compounds. Examples of nucleic acids include DNA, RNA, and PNA. A single-stranded nucleic acid having a specific base sequence selectively hybridizes and binds to a single-stranded nucleic acid having a base sequence complementary to the base sequence or a part of the base sequence, and thus corresponds to a selective binding substance. Examples of proteins include antibodies, antigen-binding fragments of antibodies such as Fab fragments and F(ab')2 fragments, and various antigens. An antibody or its antigen-binding fragment selectively binds to a corresponding antigen, and an antigen selectively binds to a corresponding antibody, and thus corresponds to a selective binding substance. Examples of sugars include polysaccharides, and various antigens. Substances having antigenicity other than proteins and sugars can also be immobilized. The selective binding substance used in the present invention may be commercially available or may be obtained from living cells, etc. As the selective binding substance, particularly preferred is nucleic acid. Among nucleic acids, oligonucleic acids having a length of 10 to 100 bases are preferred because they can be easily artificially synthesized by a synthesizer and can be easily modified with amino groups at the nucleic acid end, which facilitates immobilization on the substrate surface. From the viewpoint of hybridization stability, the length is more preferably 20 to 100 bases. As functional groups capable of modifying the end of a nucleic acid, in addition to amino groups, formyl groups, epoxy groups, carboxyl groups, hydroxyl groups, or thiol groups (sulfanyl groups) can also be preferably used. Among these, amino groups are preferred. Methods for binding these functional groups to the end of a nucleic acid are well known, and for example, binding an amino group to the end of a nucleic acid can be performed by binding an amidite reagent containing an amino group (Reference: International Publication WO 2013 / 024694).

[0048] In the biochip of the present invention, the selective binding substance is immobilized on the substrate surface via a covalent bond with the polymer bound to the substrate by the above-mentioned method. The selective binding substance and the polymer may be covalently bound directly to a reactive functional group in the polymer, or may be bound using a known crosslinking agent. Examples of known crosslinking agents include homolinkers such as 1,4-phenylenediisocyanate, 1,4-butanediol diglycidyl ether, and 1,4-phenylenediisothiocyanate, and heterolinkers such as 4-(N-maleimidomethyl)cyclohexane carboxylate N-succinimidyl (SMCC) and maleimidoacetate N-succinimidyl (AMAS). More specifically, the covalent bond between the selective binding substance and the polymer can be achieved, for example, by immersing the substrate on which the polymer is immobilized in a dimethyl sulfoxide solution of 1,4-phenylenediisothiocyanate (preferable concentration is 10 to 50% by weight), maintaining the solution at a temperature of preferably 0°C to 40°C for 1 to 10 hours, and then contacting the substrate with an aqueous solution of the selective binding substance (preferable concentration is 0.1 to 10% by weight), maintaining the solution at a temperature of preferably 0°C to 40°C for 1 to 100 hours.

[0049] The measurement target substance of the biochip of the present invention is a substance selectively bound by the selective binding substance, and examples thereof include nucleic acids, proteins, and peptides. Examples of nucleic acids include cell-free DNA, genomic DNA, messenger RNA, microRNA, and artificially synthesized nucleic acids. Examples of proteins include antibodies, antigens, cytokines, and allergens. Furthermore, the measurement target substance may be one that has been labeled in advance with a fluorescent substance or the like.

[0050] The measurement of the target substance by the biochip of the present invention may be performed by a known method. Usually, the method includes a step of contacting a sample containing the target substance with the substrate surface to form a complex with the selective binding substance, and a step of detecting the formed complex. Before this detection step, the substrate surface is usually washed. The sample may be any sample that contains the target substance or may contain the target substance, specifically, body fluids such as blood, plasma, and serum, and buffers containing the target substance. The method of detecting the complex is not particularly limited, and may be performed by a known method such as fluorescence or chemiluminescence. When the target substance is labeled with a fluorescent substance, it may be used to detect the complex, or the complex may be labeled with another fluorescent substance before detection. In addition, when measuring a signal value derived from the complex from the region where the selective binding substance is immobilized, a noise value derived from the selective binding substance nonspecifically bound to the substrate from the region where the selective binding substance is not immobilized may be measured together and used to determine the noise level. EXAMPLES

[0051] Examples are shown below, but the present invention is not limited to these examples.

[0052] Example 1 Biochips using PMMA substrates (substrates 2-6) bound with partially methoxycarbonylated polyallylamine (1) Synthesis of partially methoxycarbonylated polyallylamine (formula (IV)) A flask was charged with 100 mL (263 mmol) of a 15% by weight aqueous solution of polyallylamine (number average molecular weight 15,000, Nittobo Medical PAA-15C), and the temperature was kept at 50°C. 2.4 g of dimethyl carbonate (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd., 26.3 mmol) was added dropwise to the aqueous solution over a period of 15 minutes. After the addition was completed, the reaction was continued for 12 hours while maintaining the temperature at 50°C. After the reaction, the polymer solution was transferred to a dialysis membrane (manufactured by Spectra Corporation) and mixed with a dialysis membrane to form a dialysis membrane. PThe mixture was placed in a 10 mol% methoxycarbonyl polyallylamine column (molecular weight cutoff 3,500) and dialyzed in water to remove by-products. After purification, the water was removed by freeze-drying to obtain 10 mol% methoxycarbonyl polyallylamine. 1 H-NMR was measured, and the ratio of the area of ​​the peak derived from the methoxycarbonylated allylamine unit (2.91 ppm) to the area of ​​the peak derived from the unmodified allylamine unit (2.45 ppm) was found to confirm that the methoxycarbonylation ratio (m / (m+n)) was 10 mol%.

[0053] Using a similar method, 30 mol% methoxycarbonylated polyallylamine was obtained using 7.1 g of dimethyl carbonate (FUJIFILM Wako Pure Chemical Industries, Ltd., 78.9 mmol), 50 mol% methoxycarbonylated polyallylamine was obtained using 11.9 g of dimethyl carbonate (FUJIFILM Wako Pure Chemical Industries, Ltd., 132 mmol), 70 mol% methoxycarbonylated polyallylamine was obtained using 16.6 g of dimethyl carbonate (FUJIFILM Wako Pure Chemical Industries, Ltd., 184 mmol), and 90 mol% methoxycarbonylated polyallylamine was obtained using 21.3 g of dimethyl carbonate (FUJIFILM Wako Pure Chemical Industries, Ltd., 237 mmol).

[0054] [ka]

[0055] In the formula, m and n are each independently a positive number, and therefore m / (m+n) and n / (m+n) represent the molar ratios of each unit.

[0056] (2) Preparation of NHS-esterified PMMA substrate (substrate 1) A polymethyl methacrylate (PMMA) plate (75 mm x 25 mm x 1 mm) was immersed in a 10N sodium hydroxide solution at 70°C for 15 hours. It was then washed with pure water, a 0.1N HCl solution, and pure water, in that order. In this way, the side chains of PMMA on the substrate surface were hydrolyzed to generate carboxyl groups.

[0057] Next, 100 mg of N-hydroxysuccinimide (NHS) and 350 mg of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) were dissolved in 400 mL of 2-morpholinoethanesulfonic acid monohydrate (MES) buffer (adjusted to pH 5.0 with 0.1 N sodium hydroxide). The hydrolyzed PMMA substrate was immersed in the mixed solution and stirred with a micro stirrer for 1 hour to obtain an NHS-esterified PMMA substrate (substrate 1).

[0058] (3) Preparation of PMMA substrates (substrates 2-6) bound with partially methoxycarbonylated polyallylamine The NHS-esterified PMMA substrate (substrate 1) obtained in (2) above was immersed in 400 mL of borate buffer (100 mM, adjusted to pH 10 with 1N sodium hydroxide) in which the 10 mol % methoxycarbonyl polyallylamine obtained in (1) above was dissolved to a concentration of 1 wt %, and stirred with a microstirrer for 1 hour. After stirring, the substrate was immersed in 400 mL of dimethyl sulfoxide solution in which 100 mg of 1,4-phenylenediisothiocyanate was dissolved as a crosslinking agent, and stirred with a microstirrer for 1 hour to obtain a 10 mol % methoxycarbonyl polyallylamine-bonded PMMA substrate (substrate 2).

[0059] Using a similar method, a 30 mol% methoxycarbonylated polyallylamine-bonded PMMA substrate (substrate 3) was obtained by using 30 mol% methoxycarbonylated polyallylamine, a 50 mol% methoxycarbonylated polyallylamine-bonded PMMA substrate (substrate 4) was obtained by using 50 mol% methoxycarbonylated polyallylamine, a 70 mol% methoxycarbonylated polyallylamine-bonded PMMA substrate (substrate 5) was obtained by using 70 mol% methoxycarbonylated polyallylamine, and a 90 mol% methoxycarbonylated polyallylamine-bonded PMMA substrate (substrate 6) was obtained by using 90 mol% methoxycarbonylated polyallylamine.

[0060] (4) Immobilization of probe DNA on the substrate As a probe DNA, a DNA consisting of the base sequence of SEQ ID NO:1 was synthesized. 5'-AACTATACAACCTACTACCTCA-3' (SEQ ID NO: 1: 23 bases, 5'-end aminated). This DNA was dissolved in pure water at a concentration of 100 μM to prepare a stock solution. The stock solution was diluted 5-fold with PBS (NaCl 8 g, Na2HPO4, 12H2O 2.9 g, KCl 0.2 g, K2PO4 0.2 g dissolved in pure water and made up to 1 liter. pH 7.4) to prepare a spotting solution. Approximately 40 μl of the spotting solution was taken out, and using a spotting robot (Japan Laser Electronics Co., Ltd., GTMAS Stamp-2), 6 × 4 = 24 DNA spots were performed on the center of each substrate (substrates 2 to 6) prepared in (3) above. After spotting, the substrate was placed in a sealed plastic container and incubated at 37 °C and 100% humidity for about 20 hours to immobilize the probe DNA. After incubation, the substrate was washed with pure water.

[0061] (5) Hybridization to a substrate with immobilized probe DNA Total RNA (Thermo Fisher Scientific) derived from prostate tissue was fluorescently labeled with miRNA using a 3D-Gene (registered trademark) miRNA Labeling kit (Toray Industries, Inc.) according to the protocol established by the company, to prepare a stock solution. The stock solution was 1% by weight BSA (bovine serum albumin), 5xSSC (5xSSC is 43.8g NaCl, 22.1g trisodium citrate hydrate dissolved in pure water and made up to 200ml. Also, 43.8g NaCl, 22.1g trisodium citrate hydrate dissolved in pure water and made up to 1L is referred to as 1xSSC, and a 10-fold concentrated solution of this is referred to as 10xSSC, and a 5-fold diluted solution is referred to as 0.2xSSC.), 0.1% by weight SDS (sodium dodecyl sulfate), and 0.01% by weight salmon sperm DNA solution (all concentrations are final concentrations) diluted 50-fold to prepare a hybridization solution. 100μl of the hybridization solution was dropped onto each substrate (substrates 2-6) on which the probe DNA was immobilized, and a cover glass was placed on top of it. The cover glass was sealed with paper glue to prevent the hybridization solution from drying out. This was placed in a plastic container and incubated at 35°C and 100% humidity for 12 hours to perform hybridization. After incubation, the cover glass was peeled off, washed, and dried.

[0062] (6) Fluorescence measurement of hybridized biochip "3D - The hybridized substrate was set in a Gene" (registered trademark) Scanner (Toray Industries, Inc.), and measurements were performed under conditions of excitation light of 635 nm, laser output of 100%, and PMT of 30. The results are shown in Table 1.

[0063] Example 2 Biochips using partially acetylated polyallylamine-bound PMMA substrates (substrates 7-9) (1) Synthesis of partially acetylated polyallylamine (formula (V)) A flask was charged with 100 mL (263 mmol) of a 15 wt % aqueous polyallylamine solution (number average molecular weight 15,000, Nittobo Medical PAA-15C), and the temperature was kept at 50°C. 8.1 g of acetic anhydride (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd., 78.9 mmol) was added dropwise to the aqueous solution over 15 minutes. After the addition was complete, the reaction was continued for 12 hours while maintaining the temperature at 50°C. After the reaction, an aqueous sodium hydroxide solution (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd., 8N) was added until the pH was 11, and the polymer solution was then passed through a dialysis membrane (manufactured by Spectra Corporation). P The mixture was placed in heavy water (3, molecular weight cutoff 3,500) and dialyzed in water to remove by-products. After purification, the water was removed by freeze-drying to obtain 30 mol% acetylated polyallylamine. 1 H-NMR was measured, and the acetylation ratio (m / (m+n)) was confirmed to be 30 mol% from the ratio of the area of ​​the peak derived from the acetylated allylamine unit (2.87 ppm) to the area of ​​the peak derived from the unmodified allylamine unit (2.45 ppm).

[0064] In a similar manner, 50 mol % acetylated polyallylamine was obtained by using 13.5 g (132 mmol) of acetic anhydride, and 70 mol % acetylated polyallylamine was obtained by using 18.8 g (184 mmol) of acetic anhydride.

[0065] [ka]

[0066] In the formula, m and n are each independently a positive number, and m / (m+n) and n / (m+n) represent the molar ratios of each unit.

[0067] (2) Preparation of partially acetylated polyallylamine-bound PMMA substrates (substrates 7-9) Using methods similar to those in (2) and (3) of Example 1, a 30 mol% acetylated polyallylamine-bonded PMMA substrate (substrate 7) was obtained by using 30 mol% acetylated polyallylamine, a 50 mol% acetylated polyallylamine-bonded PMMA substrate (substrate 8) was obtained by using 50 mol% acetylated polyallylamine, and a 70 mol% acetylated polyallylamine-bonded PMMA substrate (substrate 9) was obtained by using 70 mol% acetylated polyallylamine.

[0068] (3) Immobilization of probe DNA on the substrate and evaluation A probe DNA was immobilized on each substrate obtained in (2) above in the same manner as in (4) of Example 1 to obtain a biochip. Fluorescence measurement after hybridization was performed on the obtained biochip in the same manner as in (5) and (6) of Example 1. The results are shown in Table 1.

[0069] Example 3 Partial Cal B Biochips using PMMA substrates (substrates 10-12) bound to molylated polyallylamine

[0070] (1) Partial Cal B Synthesis of molylated polyallylamine (formula (VI)) A flask was charged with 100 mL (263 mol) of a 15 wt% aqueous polyallylamine solution (number average molecular weight 15,000, Nittobo Medical PAA-15C), and 21.9 g (263 mol) of concentrated hydrochloric acid (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.) was added dropwise under ice cooling. The mixture was then heated to 50°C, and 68.4 g of a 7.5 wt% aqueous sodium cyanate solution (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd., 78.9 mmol) was added dropwise, and the reaction was carried out for 24 hours. After the reaction, an aqueous sodium hydroxide solution (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd., 8N) was added until the pH reached 11, and the polymer solution was then passed through a dialysis membrane (manufactured by Spectra Corporation, P The mixture was placed in a 30 mol% CaCl2O3 flask (molecular weight cutoff 3,500) and dialyzed in water to remove by-products. After purification, the water was removed by freeze-drying to obtain a 30 mol% CaCl2O3 solution. B The molylated polyallylamine was obtained.1 H-NMR was measured and the cal B The ratio of the area of ​​the peak derived from the molylated allylamine unit (2.88 ppm) to that derived from the unmodified allylamine unit (2.51 ppm) was used to determine the B The moylation ratio (m / (m+n)) was confirmed to be 30 mol%.

[0071] In the same manner, 114.4 g (132 mmol) of 7.5 wt% sodium cyanate solution was used to obtain 50 mol% calcium carbonate. B The molylated polyallylamine was synthesized at 70 mol% by using 159.5 g (184 mmol) of a 7.5 wt% aqueous solution of sodium cyanate. Carbamoyl Thus, polyallylamine was obtained.

[0072] [ka]

[0073] In the formula, m and n are each independently a positive number, and therefore m / (m+n) and n / (m+n) represent the molar ratios of each unit.

[0074] (2) Preparation of partially carbamoylated polyallylamine-bound PMMA substrates (substrates 10-12) In the same manner as in (2) and (3) of Example 1, 30 mol% calcium carbonate was added. B By using molylated polyallylamine, 30 mol% calcium carbonate was obtained. B The PMMA substrate (substrate 10) bound with 50 mol% calcium phosphate was B By using molylated polyallylamine, 50 mol% calcium carbonate was obtained. B The PMMA substrate (substrate 11) bound with 70 mol% calcium phosphate was B By using molylated polyallylamine, 70 mol% calcium carbonate was obtained. B A PMMA substrate (substrate 12) bound with molylated polyallylamine was obtained.

[0075] (3) Immobilization of probe DNA on the substrate and evaluation A probe DNA was immobilized on each substrate obtained in (2) above in the same manner as in (4) of Example 1 to obtain a biochip. Fluorescence measurement after hybridization was performed on the obtained biochip in the same manner as in (5) and (6) of Example 1. The results are shown in Table 1.

[0076] Comparative Example 1 Biochip using NHS-esterified PMMA substrate (substrate 1) A biochip was obtained by immobilizing a probe DNA on the NHS-esterified PMMA substrate (substrate 1) obtained in (2) of Example 1 in the same manner as in (4) of Example 1. Fluorescence measurement after hybridization was performed on the obtained biochip in the same manner as in (5) and (6) of Example 1. The results are shown in Table 1.

[0077] Comparative Example 2 Polyethyleneimine-bonded PMMA substrate (Substrate 13) (1) Preparation of polyethyleneimine-bonded PMMA substrate (substrate 13) Polyethyleneimine (number average molecular weight 10,000, Nippon Shokubai SP-200) was used in the same manner as in (2) and (3) of Example 1 to obtain a polystyrene. Ethylene A substrate made of min-bonded PMMA (substrate 13) was obtained.

[0078] (2) Immobilization of probe DNA on the substrate and evaluation A biochip was obtained by immobilizing a probe DNA on the substrate obtained in (1) above in the same manner as in (4) of Example 1. Fluorescence measurement after hybridization was performed on the obtained biochip in the same manner as in (5) and (6) of Example 1. The results are shown in Table 1.

[0079] Comparative Example 3 Biochip using polyallylamine-bound PMMA substrate (substrate 14) (1) Preparation of polyallylamine-bound PMMA substrate (substrate 14) A polyallylamine-bonded PMMA substrate (substrate 14) was obtained using polyallylamine (number average molecular weight 15,000, Nittobo Medical PAA-15C) in the same manner as in (2) and (3) of Example 1.

[0080] (2) Immobilization of probe DNA on the substrate and evaluation A biochip was obtained by immobilizing a probe DNA on the substrate obtained in (1) above in the same manner as in (4) of Example 1. Fluorescence measurement after hybridization was performed on the obtained biochip in the same manner as in (5) and (6) of Example 1. The results are shown in Table 1.

[0081] Comparative Example 4 Biochip using a PMMA substrate (substrate 15) bound with partially carboxymethylated polyallylamine (1) Synthesis of partially carboxymethylated polyallylamine (formula (VII)) A flask was charged with 100 mL (263 mol) of a 15% by weight aqueous solution of polyallylamine (number average molecular weight 15,000, Nittobo Medical PAA-15C), heated to 50°C, and 9.1 g of bromoacetic acid (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd., 65.8 mmol) was added dropwise and reacted for 24 hours. After the reaction, an aqueous solution of sodium hydroxide (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd., 8N) was added until the pH reached 11, and the polymer solution was then passed through a dialysis membrane (manufactured by Spectra Medical Co., Ltd.) to obtain a dialysis solution. P The mixture was placed in a 3-well flask (molecular weight cutoff 3,500) and dialyzed in water to remove by-products. After purification, the water was removed by freeze-drying to obtain 25 mol% carboxymethylated polyallylamine. 1 H-NMR was measured, and the carboxymethylation ratio (m / (m+n)) was confirmed to be 25 mol% from the ratio of the area of ​​the peak derived from the carboxymethylated allylamine unit (2.61 ppm) to the area of ​​the peak derived from the unmodified allylamine unit (2.51 ppm).

[0082] [ka]

[0083] In the formula, m and n are each independently a positive number, and m / (m+n) and n / (m+n) represent the molar ratios of each unit.

[0084] (2) Preparation of partially carboxymethylated polyallylamine-bound PMMA substrate (substrate 15) A 25 mol % carboxymethylated polyallylamine-bonded PMMA substrate (substrate 15) was obtained by using 25 mol % carboxymethylated polyallylamine in the same manner as in (2) and (3) of Example 1.

[0085] (3) Immobilization of probe DNA on the substrate and evaluation A biochip was obtained by immobilizing a probe DNA on the substrate obtained in (2) above in the same manner as in (4) of Example 1. Fluorescence measurement after hybridization was performed on the obtained biochip in the same manner as in (5) and (6) of Example 1. The results are shown in Table 1.

[0086] [Table 1]

[0087] Table 1 shows the fluorescence value (signal value) of the portion of the hybridized substrate where the probe DNA is immobilized, the fluorescence value (noise value) of the portion where the probe DNA is not immobilized, and the ratio of the noise value to the signal value (SN ratio). The fluorescence detected here is derived from the fluorescent dye contained in the labeling kit and the RNA fluorescently labeled by the labeling kit, and the higher the binding amount of these, the higher the value. The signal value corresponds to the amount of fluorescently labeled RNA having a sequence complementary to the probe DNA bound by hybridization with the probe DNA. On the other hand, the noise value corresponds to the amount of fluorescent dye and fluorescently labeled RNA nonspecifically bound to the substrate. The SN ratio is used as an index of the detection sensitivity of the biochip because the more RNA is bound to the probe DNA by hybridization and the less nonspecific binding of RNA and fluorescent dye to the substrate, the higher the value.

[0088] Substrates (Example 1, Substrates 2-6) bonded with partially methoxycarbonylated polyallylamine obtained by modifying the side chain amino groups of polyallylamine showed high S / N ratios not only compared with a substrate not bonded with a polymer (Comparative Example 1, Substrate 1), but also compared with a substrate bonded with polyethyleneimine (Comparative Example 2, Substrate 13) and a substrate bonded with polyallylamine (Comparative Example 3, Substrate 14). This is presumably due to the effect of the modification with methoxycarbonyl groups in suppressing nonspecific adsorption of fluorescent dyes, which is the cause of increased noise values, and the improvement of hybridization efficiency by adjusting the density of reactive functional groups on the substrate surface.

[0089] Similar effects were observed in the substrates bonded with partially acetylated polyallylamine (Example 2, Substrates 7-9) and partially carbamoylated polyallylamine (Example 3, Substrates 10-12). On the other hand, no effect was observed in the substrate bonded with partially carboxymethylated polyallylamine (Comparative Example 4, Substrate 15). From the above results, it was found that the type of functional group modified on the polymer is important in order to obtain a biochip with excellent signal value and SN ratio.

[0090] Example 4 Biochips using PMMA substrates (substrates 16-18) with partial propanamide modification and polyallylamine bonding

[0091] (1) Synthesis of partially propanamide-modified polyallylamine (formula (VIII)) A flask was charged with 100 mL (263 mmol) of a 15% by weight aqueous solution of polyallylamine (number average molecular weight 15,000, Nittobo Medical PAA-15C), and the temperature was kept at 50°C. An aqueous solution of 5.6 g of acrylamide (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd., 78.9 mmol) dissolved in 50 mL of distilled water was added dropwise to the aqueous solution over a period of 15 minutes. After the addition was complete, the reaction was continued for 12 hours while maintaining the temperature at 50°C. After the reaction, the polymer solution was transferred to a dialysis membrane (manufactured by Spectra Corporation) and mixed with a dialysis membrane to form a dialysis membrane. P The mixture was placed in heavy water (3, molecular weight cutoff 3,500) and dialyzed in water to remove by-products. After purification, the water was removed by freeze-drying to obtain 30 mol% propanamide-modified polyallylamine. 1 H-NMR was measured, and the ratio of the area of ​​the peak derived from the propanamide-modified allylamine unit (2.62 ppm) to the area of ​​the peak derived from the unmodified allylamine unit (2.45 ppm) was found to be 30 mol%.

[0092] Using a similar method, 50 mol% propanamide-modified polyallylamine was obtained using 9.4 g of acrylamide (Fujifilm Wako Pure Chemical Industries, Ltd., 132 mmol), and 70 mol% propanamide-modified polyallylamine was obtained using 13.1 g of acrylamide (Fujifilm Wako Pure Chemical Industries, Ltd., 184 mmol).

[0093] [ka]

[0094] In the formula, m and n are each independently a positive number, and m / (m+n) and n / (m+n) represent the molar ratios of each unit.

[0095] (2) Preparation of NHS-esterified PMMA substrate (substrate 1) An NHS-esterified PMMA substrate (Substrate 1) was prepared in the same manner as in Example 1(2).

[0096] (3) Preparation of PMMA substrates (substrates 16-18) with partial propanamide modification and polyallylamine bonding The NHS-esterified PMMA substrate (Substrate 1) prepared in (2) was immersed in 400 mL of borate buffer (100 mM, adjusted to pH 10 with 1N sodium hydroxide) in which the 30 mol% propanamide-modified polyallylamine obtained in (1) above was dissolved to a concentration of 1% by weight, and stirred with a microstirrer for 1 hour. After stirring, the substrate was immersed in 400 mL of dimethyl sulfoxide solution in which 100 mg of 1,4-phenylenediisothiocyanate was dissolved as a crosslinking agent, and stirred with a microstirrer for 1 hour to obtain a 30 mol% propanamide-modified polyallylamine-bonded PMMA substrate (Substrate 16).

[0097] Using a similar method, a 50 mol% propanamide-modified polyallylamine-bonded PMMA substrate (substrate 17) was obtained by using 50 mol% propanamide-modified polyallylamine, and a 70 mol% propanamide-modified polyallylamine-bonded PMMA substrate (substrate 18) was obtained by using 70 mol% propanamide-modified polyallylamine.

[0098] (4) Immobilization of probe DNA on the substrate As in Example 1(4), a DNA consisting of the base sequence of SEQ ID NO: 1 (23 bases, 5'-end aminated) was used as a probe DNA and immobilized on each substrate in the same manner as in Example 1.

[0099] (5) Hybridization to a substrate with immobilized probe DNA Hybridization to the substrate on which the probe DNA was immobilized was carried out in the same manner as in Example 1(5).

[0100] (6) Fluorescence measurement of hybridized biochip The fluorescence of the biochip after hybridization was measured in the same manner as in (6) of Example 1. The results are shown in Table 2.

[0101] Example 5 Biochip using a PMMA substrate (substrate 19) partially modified with N,N-dimethylpropanamide and bound with polyallylamine (1) Synthesis of partially N,N-dimethylpropanamide modified polyallylamine (formula (IX)) A flask was charged with 100 mL (263 mmol) of a 15 wt % aqueous polyallylamine solution (number average molecular weight 15,000, Nittobo Medical PAA-15C), and the temperature was kept at 50°C. An aqueous solution of 13.1 g of N,N-dimethylacrylamide (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd., 132 mmol) dissolved in 50 mL of distilled water was added dropwise to the aqueous solution over a period of 15 minutes. After the addition was complete, the reaction was continued for 12 hours while maintaining the temperature at 50°C. After the reaction, the polymer solution was transferred to a dialysis membrane (manufactured by Spectra Corporation) and mixed with a dialysis membrane to form a dialysis membrane. P The mixture was placed in a 3-well flask (molecular weight cutoff 3,500) and dialyzed in water to remove by-products. After purification, the water was removed by freeze-drying to obtain 50 mol% N,N-dimethylpropanamide modified polyallylamine. 1 H-NMR was measured, and the ratio of the area of ​​the peak (2.62 ppm) derived from the N,N-dimethylpropanamide-modified allylamine unit to the area of ​​the peak (2.45 ppm) derived from the unmodified allylamine unit was found to be 50 mol%.

[0102] [ka]

[0103] In the formula, m and n are each independently a positive number, and m / (m+n) and n / (m+n) represent the molar ratios of each unit.

[0104] (2) Preparation of a PMMA substrate (substrate 19) partially modified with N,N-dimethylpropanamide and bound with polyallylamine A 50 mol % N,N-dimethylpropanamide-modified polyallylamine-bonded PMMA substrate (Substrate 19) was obtained by using 50 mol % N,N-dimethylpropanamide-modified polyallylamine in the same manner as in (2) and (3) of Example 4.

[0105] (3) Immobilization of probe DNA on the substrate and evaluation A probe DNA was immobilized on each substrate obtained in (2) above in the same manner as in (4) of Example 4 to obtain a biochip. Fluorescence measurement after hybridization was performed on the obtained biochip in the same manner as in (5) and (6) of Example 4. The results are shown in Table 2.

[0106] Example 6 Biochip using a PMMA substrate (substrate 20) partially modified with N,N-diethylpropanamide and bound with polyallylamine (1) Synthesis of partially N,N-diethylpropanamide modified polyallylamine (formula (X)) A flask was charged with 100 mL (263 mmol) of a 15 wt % aqueous polyallylamine solution (number average molecular weight 15,000, Nittobo Medical PAA-15C), and the temperature was kept at 50°C. An aqueous solution of 16.8 g of N,N-diethylacrylamide (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd., 132 mmol) dissolved in 50 mL of distilled water was added dropwise to the aqueous solution over a period of 15 minutes. After the addition was complete, the reaction was continued for 12 hours while maintaining the temperature at 50°C. After the reaction, the polymer solution was transferred to a dialysis membrane (manufactured by Spectra Corporation) and mixed with a dialysis membrane to form a dialysis membrane. P The mixture was placed in a 3-well flask (molecular weight cutoff 3,500) and dialyzed in water to remove by-products. After purification, the water was removed by freeze-drying to obtain 50 mol% N,N-diethylpropanamide modified polyallylamine. 1H-NMR was measured, and the ratio of the area of ​​the peak (2.64 ppm) derived from the N,N-diethylpropanamide-modified allylamine unit to the area of ​​the peak (2.45 ppm) derived from the unmodified allylamine unit was confirmed to be 50 mol%.

[0107] [ka]

[0108] In the formula, m and n are each independently a positive number, and therefore m / (m+n) and n / (m+n) represent the molar ratios of each unit.

[0109] (2) Preparation of a PMMA substrate (substrate 20) partially modified with N,N-diethylpropanamide and bound with polyallylamine A 50 mol % N,N-diethylpropanamide-modified polyallylamine-bonded PMMA substrate (substrate 20) was obtained by using 50 mol % N,N-diethylpropanamide-modified polyallylamine in the same manner as in (2) and (3) of Example 4.

[0110] (3) Immobilization of probe DNA on the substrate and evaluation Probe DNA was immobilized on each substrate obtained in (2) above in the same manner as in (4) of Example 4 to obtain a biochip. Fluorescence measurement after hybridization was performed on the obtained biochip in the same manner as in (5) and (6) of Example 4. The results are shown below. 2 As shown in.

[0111] Example 7 Biochip using PMMA substrate partially modified with N-isopropylpropanamide and polyallylamine (substrate 21) (1) Synthesis of partially N-isopropylpropanamide modified polyallylamine (formula (XI)) A flask was charged with 100 mL (263 mmol) of a 15% by weight aqueous solution of polyallylamine (number average molecular weight 15,000, Nittobo Medical PAA-15C), and the temperature was kept at 50°C. An aqueous solution of 14.9 g of N-isopropylacrylamide (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd., 132 mmol) dissolved in 50 mL of distilled water was added dropwise to the aqueous solution over a period of 15 minutes. After the addition was complete, the reaction was continued for 12 hours while maintaining the temperature at 50°C. After the reaction, the polymer solution was transferred to a dialysis membrane (manufactured by Spectra Corporation) and mixed with a dialysis membrane to form a dialysis membrane. P The mixture was placed in a 3-well flask (molecular weight cutoff 3,500) and dialyzed in water to remove by-products. After purification, the water was removed by freeze-drying to obtain 50 mol% N-isopropylpropanamide modified polyallylamine. 1 H-NMR was measured, and the ratio of the area of ​​the peak (2.60 ppm) derived from the N-isopropylpropanamide-modified allylamine unit to the area of ​​the peak (2.45 ppm) derived from the unmodified allylamine unit was found to be 50 mol%.

[0112] [ka]

[0113] In the formula, m and n are each independently a positive number, and m / (m+n) and n / (m+n) represent the molar ratios of each unit.

[0114] (2) Preparation of a PMMA substrate (substrate 7) partially modified with N-isopropylpropanamide and bound with polyallylamine A 50 mol % N-isopropylpropanamide-modified polyallylamine-bonded PMMA substrate (substrate 21) was obtained by using 50 mol % N-isopropylpropanamide-modified polyallylamine in the same manner as in (2) and (3) of Example 4.

[0115] (3) Immobilization of probe DNA on the substrate and evaluation Probe DNA was immobilized on each substrate obtained in (2) above in the same manner as in (4) of Example 4 to obtain a biochip. Fluorescence measurement after hybridization was performed on the obtained biochip in the same manner as in (5) and (6) of Example 4. The results are shown in Table 2. For ease of comparison, Table 2 also shows the results of Comparative Examples 1 to 4 shown in Table 1.

[0116] [Table 2]

[0117] Example 8 Biochips with egg white allergen immobilized on PMMA substrates (substrates 3 to 5) with partial methoxycarbonyl-modified polyallylamine (1) Immobilization of egg white allergen on a substrate Egg white allergen was obtained from GREER as a freeze-dried powder, and the freeze-dried powder was dissolved in pure water to a protein concentration of 1.0 mg / mL to prepare a spotting solution. Using a spotting robot (Japan Laser Electronics Co., Ltd., GTMAS Stamp-2), 6 x 4 = 24 spots of egg white allergen were spotted in the center of each substrate (substrates 3 to 5) prepared in (3) of Example 1. After spotting, the substrate was placed in a sealed plastic container and incubated at 37°C and 100% humidity for about 20 hours to immobilize the egg white allergen. After incubation, the substrate was washed with phosphate buffered saline (0.05% Tween 20 (trade name)).

[0118] (2) Contact of egg white allergy positive human serum with the substrate on which the egg white allergen was immobilized Egg white allergy positive human serum was obtained from PlasmaLab and diluted 3-fold with phosphate buffered saline, and 50 μL of the diluted solution was dropped onto the substrate prepared in (1), and the substrate was covered and sealed with a gap cover glass (manufactured by Matsunami Glass Industry Co., Ltd.: 24 mm × 25 mm, gap size 20 μm). After reacting at 37°C for 2 hours, the gap cover glass was removed, and the substrate was washed with phosphate buffered saline (0.05% Tween 20 (trade name)).

[0119] (3) Detection of egg white allergen-specific IgE antibodies A 1.0 mg / mL solution of Dylight-650 dye-labeled anti-human IgE goat polyclonal antibody (Novus biologicals) was diluted 1000-fold with phosphate-buffered saline (0.05% Tween 20 (trade name)) containing 1% by weight of bovine serum albumin. 50 μL of this diluted solution was dropped onto the substrate that had been contacted with human serum in (2), and the substrate was covered with a gap cover glass and reacted at room temperature for 1 hour. Thereafter, the gap cover glass was removed, and the substrate was washed with phosphate-buffered saline (0.05% Tween 20 (trade name)).

[0120] "3D - The substrate was set in a Gene" (registered trademark) Scanner (Toray Industries, Inc.), and measurements were performed under conditions of excitation light of 635 nm, laser output of 100%, and PMT of 30. The results are shown in Table 3.

[0121] Example 9 Biochips with egg white allergen immobilized on PMMA substrates (substrates 22-24) with partial ethoxycarbonyl-modified polyallylamine (1) Synthesis of partially ethoxycarbonyl-modified polyallylamine (chemical formula (XII)) A flask was charged with 100 mL (263 mmol) of a 15% by weight aqueous solution of polyallylamine (number average molecular weight 15,000, Nittobo Medical PAA-15C), and the temperature was kept at 50°C. 9.32 g of diethyl carbonate (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd., 78.9 mmol) was added dropwise to the aqueous solution over a period of 15 minutes. After the addition was completed, the reaction was continued for 12 hours while maintaining the temperature at 50°C. After the reaction, the polymer solution was transferred to a dialysis membrane (manufactured by Spectra Corporation) and mixed with a dialysis membrane to form a dialysis membrane. PThe polyallylamine was placed in a 3-well plate (molecular weight fraction 3,500) and dialyzed in water to remove by-products. After purification, the water was removed by freeze-drying to obtain a 30 mol% ethoxycarbonylated polyallylamine. 1H-NMR was measured in heavy water, and the ratio of the area of ​​the peak derived from the ethoxycarbonylated allylamine unit (2.87 ppm) to the peak derived from the unmodified allylamine unit (2.47 ppm) confirmed that the ethoxycarbonyl modification ratio (m / (m+n)) was 30 mol%.

[0122] Using a similar method, 50 mol% ethoxycarbonyl-modified polyallylamine was obtained using 15.6 g of diethyl carbonate (Fujifilm Wako Pure Chemical Industries, Ltd., 132 mmol), and 70 mol% ethoxycarbonyl-modified polyallylamine was obtained using 21.8 g of diethyl carbonate (Fujifilm Wako Pure Chemical Industries, Ltd., 184 mmol).

[0123] [ka]

[0124] (2) Preparation of partially ethoxycarbonyl-modified polyallylamine-bonded PMMA substrates (substrates 22-24) Using methods similar to those in (2) and (3) of Example 1, a 30 mol% ethoxycarbonyl-modified polyallylamine-bonded PMMA substrate (substrate 22) was obtained by using 30 mol% ethoxycarbonyl-modified polyallylamine, a 50 mol% ethoxycarbonyl-modified polyallylamine-bonded PMMA substrate (substrate 23) was obtained by using 50 mol% ethoxycarbonyl-modified polyallylamine, and a 70 mol% ethoxycarbonyl-modified polyallylamine-bonded PMMA substrate (substrate 24) was obtained by using 70 mol% ethoxycarbonyl-modified polyallylamine.

[0125] (3) Immobilization of egg white allergen on a substrate and evaluation On each of the substrates obtained in (2) above, the egg white allergen was immobilized in the same manner as in (1) of Example 8 to obtain a biochip. The obtained biochip was contacted with human serum positive for egg white allergy and then subjected to fluorescence measurement in the same manner as in (2) and (3) of Example 8. The results are shown in Table 3.

[0126] Example 10 Biochips with egg white allergen immobilized on PMMA substrates (substrates 25-27) with partial propyloxycarbonyl-modified polyallylamine (1) Synthesis of partially propyloxycarbonyl-modified polyallylamine (chemical formula (XIII)) A flask was charged with 100 mL (263 mmol) of a 15 wt % aqueous polyallylamine solution (number average molecular weight 15,000, Nittobo Medical PAA-15C), and the temperature was kept at 50°C. 11.5 g of dipropyl carbonate (Sigma-Aldrich, 78.9 mmol) was added dropwise to the aqueous solution over a period of 15 minutes. After the addition was complete, the reaction was continued for 12 hours while maintaining the temperature at 50°C. After the reaction, the polymer solution was transferred to a dialysis membrane (Spectra P The polyallylamine was placed in a 3-well plate (molecular weight fraction 3,500) and dialyzed in water to remove by-products. After purification, the water was removed by freeze-drying to obtain a 30 mol% propyloxycarbonylated polyallylamine. 1H-NMR was measured in heavy water, and the ratio of the area of ​​the peak derived from the propyloxycarbonylated allylamine unit (2.85 ppm) to the peak derived from the unmodified allylamine unit (2.50 ppm) confirmed that the propyloxycarbonyl modification ratio (m / (m+n)) was 30 mol%.

[0127] Using a similar method, 50 mol% propyloxycarbonyl-modified polyallylamine was obtained by using 19.3 g of dipropyl carbonate (Sigma-Aldrich, 132 mmol), and 70 mol% propyloxycarbonyl-modified polyallylamine was obtained by using 26.9 g of dipropyl carbonate (Sigma-Aldrich, 184 mmol).

[0128] [ka]

[0129] (2) Preparation of PMMA substrates (substrates 25-27) with partial propyloxycarbonyl-modified polyallylamine Using methods similar to those in (2) and (3) of Example 1, a 30 mol% propyloxycarbonyl-modified polyallylamine-bonded PMMA substrate (substrate 25) was obtained by using 30 mol% propyloxycarbonyl-modified polyallylamine, a 50 mol% propyloxycarbonyl-modified polyallylamine-bonded PMMA substrate (substrate 26) was obtained by using 50 mol% propyloxycarbonyl-modified polyallylamine, and a 70 mol% propyloxycarbonyl-modified polyallylamine-bonded PMMA substrate (substrate 27) was obtained by using 70 mol% propyloxycarbonyl-modified polyallylamine.

[0130] (3) Immobilization of egg white allergen on a substrate and evaluation On each of the substrates obtained in (2) above, the egg white allergen was immobilized in the same manner as in (1) of Example 8 to obtain a biochip. The obtained biochip was contacted with human serum positive for egg white allergy and then subjected to fluorescence measurement in the same manner as in (2) and (3) of Example 8. The results are shown in Table 3.

[0131] Example 11 Biochip with egg white allergen immobilized on a PMMA substrate (substrate 17) with partial propanamide modification and polyallylamine bonding (1) Immobilization of egg white allergen onto a substrate and its evaluation An egg white allergen was immobilized on the substrate 17 obtained in (3) of Example 4 in the same manner as in (1) of Example 8 to obtain a biochip. The obtained biochip was contacted with egg white allergy-positive human serum and then subjected to fluorescence measurement in the same manner as in (2) and (3) of Example 8. The results are shown in Table 3.

[0132] Example 12 Biochip with egg white allergen immobilized on a PMMA substrate (substrate 19) partially modified with N,N-dimethylpropanamide and bound with polyallylamine (1) Immobilization of egg white allergen onto a substrate and its evaluation An egg white allergen was immobilized on the substrate 19 obtained in (3) of Example 5 in the same manner as in (1) of Example 8 to obtain a biochip. The obtained biochip was contacted with egg white allergy-positive human serum and then subjected to fluorescence measurement in the same manner as in (2) and (3) of Example 8. The results are shown in Table 3.

[0133] Example 13 A biochip in which egg white allergen is immobilized on a PMMA substrate (substrate 20) partially modified with N,N-diethylpropanamide and bound with polyallylamine. (1) Immobilization of egg white allergen onto a substrate and its evaluation An egg white allergen was immobilized on the substrate 20 obtained in (3) of Example 6 in the same manner as in (1) of Example 8 to obtain a biochip. The obtained biochip was contacted with egg white allergy-positive human serum and then subjected to fluorescence measurement in the same manner as in (2) and (3) of Example 8. The results are shown in Table 3.

[0134] Example 14 A biochip with egg white allergen immobilized on a PMMA substrate (substrate 21) partially modified with N-isopropylpropanamide and bound with polyallylamine (1) Immobilization of egg white allergen onto a substrate and its evaluation An egg white allergen was immobilized on the substrate 21 obtained in (3) of Example 7 in the same manner as in (1) of Example 8 to obtain a biochip. The obtained biochip was contacted with egg white allergy-positive human serum and then subjected to fluorescence measurement in the same manner as in (2) and (3) of Example 8. The results are shown in Table 3.

[0135] Comparative Example 5 A biochip with egg white allergen immobilized on an NHS-esterified PMMA substrate (substrate 1) An egg white allergen was immobilized on the substrate 1 obtained in (2) of Example 1 in the same manner as in (1) of Example 8 to obtain a biochip. The obtained biochip was contacted with egg white allergy-positive human serum and then subjected to fluorescence measurement in the same manner as in (2) and (3) of Example 8. The results are shown in Table 3.

[0136] Comparative Example 6 A biochip with egg white allergen immobilized on a polyallylamine-bonded PMMA substrate (substrate 14)

[0137] For the substrate 14 obtained in (1) of Comparative Example 3, the egg white allergen was immobilized in the same manner as in (1) of Example 8 to obtain a biochip. For the obtained biochip, fluorescence measurement was performed after contact with egg white allergy positive human serum in the same manner as in (2) and (3) of Example 8. The results are shown in Table 3.

[0138] [Table 3]

[0139] Table 3 shows the fluorescence value (signal value) of the part where the egg white allergen is immobilized in the substrate that has been contacted with egg white allergy-positive human serum and dye-labeled anti-human IgE goat polyclonal antibody, the fluorescence value (noise value) of the part where the egg white allergen is not immobilized, and the ratio of the noise value to the signal value (SN ratio). The fluorescence detected here is derived from the dye-labeled anti-human IgE goat polyclonal antibody, and the higher the binding amount of the dye-labeled anti-human IgE goat polyclonal antibody, the higher the value. The signal value corresponds to the amount of the dye-labeled anti-human IgE goat polyclonal antibody bound to the complex of the human IgE antibody (substance to be measured) and the egg white allergen (selective binding substance). On the other hand, the noise value corresponds to the amount of the dye-labeled anti-human IgE goat polyclonal antibody nonspecifically bound to the substrate. The SN ratio was used as an index of the detection sensitivity of the biochip, because the higher the binding of the dye-labeled anti-human IgE goat polyclonal antibody to the complex and the lower the nonspecific binding of the dye-labeled anti-human IgE goat polyclonal antibody to the substrate, the higher the SN ratio.

[0140] Substrates (Example 8, Substrates 3 to 5) bonded with partially methoxycarbonyl-modified polyallylamine obtained by modifying the side chain amino groups of polyallylamine showed a high S / N ratio compared not only with a substrate not bonded with a polymer (Comparative Example 5, Substrate 1) but also with a substrate bonded with polyallylamine (Comparative Example 6, Substrate 14). This is presumably due to the effect of the methoxycarbonyl group modification in suppressing nonspecific adsorption of dye-labeled anti-human IgE goat polyclonal antibody, which is the cause of increased noise values, and the improvement in the efficiency of formation of the above complex by adjusting the density of reactive functional groups on the substrate surface.

[0141] Similar effects were observed in the substrates bonded with partially ethoxycarbonyl-modified polyallylamine (Example 9, Substrates 22-24), partially propyloxycarbonyl-modified polyallylamine (Example 10, Substrates 25-27), partially propanamide-modified polyallylamine (Example 11, Substrate 17), partially N,N-dimethylpropanamide-modified polyallylamine (Example 12, Substrate 19), partially N,N-diethylpropanamide-modified polyallylamine (Example 13, Substrate 20), and partially N-isopropylpropanamide-modified polyallylamine (Example 14, Substrate 21). In addition, since the SN ratio differs depending on the type of functional group modified on the polymer, it was found that the type of functional group modified on the polymer is important in order to obtain a biochip with excellent signal value and SN ratio. [Industrial Applicability]

[0142] The present invention provides a biochip capable of detecting a substance to be measured with high sensitivity. By using the biochip of the present invention, more accurate molecular identification and diagnosis become possible.

Claims

1. A biochip comprising a substrate having a surface on which a selective binding substance capable of selectively binding to a substance to be measured is immobilized via a polymer containing a unit represented by formula (Ia) or (Ib). [Formula 1] [ka] In formula (Ia) and formula (Ib), R 1 represents an alkylene group having 1 to 4 carbon atoms; R 2 is R 3 , OR 4 or N.H.R. 5 indicates R 3 and R 5 each independently represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms; R 4 represents an alkyl group having 1 to 4 carbon atoms; R 6 represents an alkylene group having 1 to 2 carbon atoms; R 7 and R 8 each independently represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms.

2. The polymer is represented by formula (Ia), 1 and R 2 The biochip according to claim 1, wherein the definition is the same as that in claim 1.

3. The polymer is represented by formula (Ib), 6 , R 7 and R 8 The biochip according to claim 1, wherein the definition is the same as that in claim 1.

4. The biochip of any one of claims 1 to 3, wherein the polymer is a heteropolymer.

5. The biochip according to claim 4 , wherein the heteropolymer is a heteropolymer with a unit represented by chemical formula (II). [Case 2] In the formula, R 1 represents an alkylene group having 1 to 4 carbon atoms.

6. The biochip according to any one of claims 1 to 5, wherein the number average molecular weight of the polymer is 300 to 1,000,000.

7. The biochip according to any one of claims 1 to 6, wherein the selective binding substance is a nucleic acid or a protein.

8. A method for detecting a substance to be measured using the biochip according to any one of claims 1 to 7, in which a selective binding substance capable of selectively binding to the substance to be measured is immobilized on the surface of a substrate, the method comprising the steps of contacting a sample containing the substance to be measured with the surface of the substrate and detecting a complex formed with the selective binding substance.

Citation Information

Patent Citations

  • Inkjet recording medium

    JP2003175668A

  • Biochip substrate and manufacturing method therefor

    JP2015040729A

  • Laminate and manufacturing method therefor

    JP2018034395A

  • Polymer coated surfaces for microarray applications

    WO2001070641A1

  • A method for forming molecular layers having high density of primary amine group on solid supports

    WO2001070851A1